These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 16885047)

  • 21. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
    Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
    J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.
    Zaoutis TE; Webber S; Naftel DC; Chrisant MA; Kaufman B; Pearce FB; Spicer R; Dipchand AI;
    Pediatr Transplant; 2011 Aug; 15(5):465-9. PubMed ID: 21108712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
    Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
    Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
    Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Candida colonization and invasive fungal infection in hospitalized patients with hematological malignancies].
    Lai YY; Bao L; Lu XJ; Lu J; Yu J; Li RY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):239-42. PubMed ID: 19552839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan.
    Kobayashi R; Kaneda M; Sato T; Ichikawa M; Suzuki D; Ariga T
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):886-90. PubMed ID: 19131772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Invasive fungal infections in hematologic malignancies--a retrospective study of 61 autopsied cases].
    Kuzuyama Y; Fujii H; Kitagawa Y; Yashige H; Horishi H; Suyama Y; Miyoshi M
    Gan No Rinsho; 1990 Jul; 36(8):899-902. PubMed ID: 2366325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients].
    Pfaffenbach B; Donhuijsen K; Pahnke J; Bug R; Adamek RJ; Wegener M; Ricken D
    Med Klin (Munich); 1994 Jun; 89(6):299-304. PubMed ID: 8072452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Invasive fungal infections in children with cancer, neutropenia and fever, in Chile].
    Lucero Y; Brücher R; Alvarez AM; Becker A; Cofré J; Enríquez N; Payá E; Salgado C; Santolaya ME; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; O'Ryan M
    Rev Med Chil; 2002 Oct; 130(10):1139-46. PubMed ID: 12491831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.
    Cesaro S; Tridello G; Castagnola E; Calore E; Carraro F; Mariotti I; Colombini A; Perruccio K; Decembrino N; Russo G; Maximova N; Baretta V; Caselli D
    Eur J Haematol; 2017 Sep; 99(3):240-248. PubMed ID: 28556426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
    Pagano L; Caira M; Fianchi L
    Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
    Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of infectious complications in hemato-oncological patients.
    Ram R; Gafter-Gvili A; Raanani P; Yeshurun M; Shpilberg O; Dreyer J; Peck A; Leibovici L; Paul M
    Isr Med Assoc J; 2009 Mar; 11(3):133-7. PubMed ID: 19544700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
    Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
    Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.